Real-time US stock event calendar and catalyst tracking for understanding upcoming market-moving announcements and investment catalysts. Our event calendar helps you prepare for earnings releases, product launches, and other important dates that could impact stock prices. We provide event calendars, catalyst tracking, and announcement monitoring for comprehensive coverage. Never miss important events with our comprehensive event calendar and catalyst tracking tools for timely investment decisions.
This analysis evaluates the investment case for UnitedHealth Group (UNH) following Goldman Sachs’ May 1, 2026, decision to add the managed care leader to its U.S. Conviction List, with a reiterated Buy rating and $435 price target. The upgrade comes on the heels of a 37% April rally for UNH, driven
UnitedHealth Group Inc. (UNH) - Goldman Sachs Conviction List Addition Signals Potential Managed Care Sector Inflection Point - P/S Ratio
UNH - Stock Analysis
4972 Comments
1826 Likes
1
Louva
Experienced Member
2 hours ago
I read this and now I need answers.
👍 260
Reply
2
Vishakan
Daily Reader
5 hours ago
This feels like a plot twist with no movie.
👍 35
Reply
3
Simrah
Engaged Reader
1 day ago
This is why timing beats everything.
👍 55
Reply
4
Richetta
Regular Reader
1 day ago
The market remains range-bound, and investors should exercise caution when entering new positions.
👍 155
Reply
5
Fanie
Elite Member
2 days ago
This feels like something I’ll regret later.
👍 48
Reply
© 2026 Market Analysis. All data is for informational purposes only.